Ardelyx (ARDX) Other Non Operating Income (2014 - 2019)
Ardelyx (ARDX) posted Other Non Operating Income of $294000.0 for Q3 2019, down 63.79% on a QoQ basis from $812000.0 in Q2 2019, and down 70.89% year-over-year from $1.0 million in Q3 2018.
Ardelyx (ARDX) Other Non Operating Income (2014 - 2019) Analysis & Trends
Ardelyx's Other Non Operating Income history runs 6 years deep, the most recent figure standing at $294000.0 for Q3 2019.
- Quarterly Other Non Operating Income fell 70.89% year-over-year to $294000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $2.9 million (up 6.14% YoY) and the FY2015 annual result came in at -$261000.0, down 2710.0% from the prior year.
- Other Non Operating Income was $294000.0 for Q3 2019 at Ardelyx, down from $812000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.0 million in Q3 2018 and bottomed at -$123000.0 in Q4 2015.
- A 5-year average of $372071.4 and a median of $397500.0 in 2017 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2015 — Other Non Operating Income slumped 1000.0% — and 2017, when it jumped 805.19%.
- Ardelyx's Other Non Operating Income stood at -$123000.0 in 2015, then soared by 162.6% to $77000.0 in 2016, then jumped by 550.65% to $501000.0 in 2017, then soared by 101.6% to $1.0 million in 2018, then tumbled by 70.89% to $294000.0 in 2019.
- Business Quant data shows ARDX's Other Non Operating Income at $294000.0 in Q3 2019, $812000.0 in Q2 2019, and $790000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 294,000.00 |
| Jun 30, 2019 | 812,000.00 |
| Mar 31, 2019 | 790,000.00 |
| Sep 30, 2018 | 1.01 Mn |
| Jun 30, 2018 | 557,000.00 |
| Mar 31, 2018 | 670,000.00 |
| Sep 30, 2017 | 501,000.00 |
| Jun 30, 2017 | 697,000.00 |
| Jun 30, 2016 | 77,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | -123,000.00 |
| Sep 30, 2015 | -77,000.00 |
| Jun 30, 2015 | -49,000.00 |
| Mar 31, 2015 | -12,000.00 |
| Dec 31, 2014 | 29,000.00 |
| Sep 30, 2014 | -7,000.00 |
| Jun 30, 2014 | -8,000.00 |
| Mar 31, 2014 | -4,000.00 |